PRN: Sepsis Diagnostics Market to Reach $874 Million by 2025 - Number of Patients Suffering from Septic Poisoning is Rising 5.7% Each Year - Research and Markets

27/feb/2017 19:15:11 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Sepsis Diagnostics Market to Reach $874 Million by 2025 - Number of Patients Suffering from Septic Poisoning is Rising 5.7% Each Year - Research and Markets


DUBLIN, Feb 27, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Sepsis Diagnostics Market 2014 - 2025" report to their offering.

The global sepsis diagnostics market is expected to reach a value of USD 874.6 million by 2025. Rising prevalence of sepsis is the most significant factor anticipated to drive the market growth during the forecast period.

According to the National Center for Biotechnology Information, the number of patients suffering from septic poisoning rose by an average of 5.7% each year. As a result of this, there is a rising need for early diagnosis of such blood-poisoning diseases amongst patients. High prevalence of sepsis is also leading to a huge mortality rate, which is triggering early diagnosis to execute the clinical intervention.

Rising number of hospital-acquired infections are also expected to support the growth of the market over the forecast period. Hospital-acquired infections majorly include urinary tract & surgical site infections, which result into sepsis. According to WHO, 7 out of every 100 hospitalized patient! s develop hospital-acquired infections in developed countries. Thus, such infections significantly cause septicemia, which will raise the need for early diagnosis. On the other hand, pneumonia is also an important driving factor for high demand of sepsis diagnostics as it is one of the major causes for septic shock.

Key Findings:

  • Blood culture media was the largest segment in 2015 due to higher adoption of culture media tests in laboratories for the diagnosis of septic poisoning.
  • Molecular diagnostics is anticipated to witness lucrative growth over the forecast period due to quick and efficient identification of microorganisms causing septicemia.
  • Bacterial sepsis contributed toward the largest revenue in 2015. This is due to the fact that bacterial infection is the most common cause for people suffering from septic poisoning.

Companies Mentioned

  • Biomérieux SA
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific Inc.
  • Roche Diagnostics
  • Cepheid Inc.
  • Beckman Coulter, Inc.
  • Nanosphere, Inc.
  • Bruker Corporation

Key Topics Covered:

1 Research Methodology

2 Executive Summary

3 Sepsis Diagnostics Market Variables, Trends & Scope

4 Sepsis Diagnostics Market: Product Estimates & Trend Analysis

5 Sepsis Diagnostics Market: Technology Estimates & Trend Analysis

6 Sepsis Diagnostics Market: Pathogen Estimates & Trend Analysis

7 Sepsis Diagnostics Market: Testing Type Estimates & Trend Analysis

8 Sepsis Diagnostics Market: Regional Estimates & Trend Analysis, by Product, Technology, Pathogen, Testing Type

9 Competitive Landscape

For more information about this report visit

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

blog comments powered by Disqus è un servizio offerto da Factotum Srl